drugset / Trial / NCT00294125
Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis
Phase 1
Completed
59 enrolled
University of Alabama at Birmingham
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collabPrimus Pharmaceuticals · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed to treat arthritis. The purpose of this study is to test the effectiveness of flavocoxid, a plant-derived compound, for the treatment of knee osteoarthritis (OA) in adults. Study hypotheses: 1) Flavocoxid has an acceptable safety and tolerability profile as determined by the Generally Regarded as Safe (GRAS) profile in patients with OA compared to identical placebo. 2) Flavocoxid will be more effective as a therapy for OA compared to identical placebo.
Timeline
- Start
- 2006-02
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | flavocoxid | Other / unclassified | 250 mg | — |